Wooree BioLtd Balance Sheet Health
Financial Health criteria checks 6/6
Wooree BioLtd has a total shareholder equity of ₩258.2B and total debt of ₩64.8B, which brings its debt-to-equity ratio to 25.1%. Its total assets and total liabilities are ₩593.6B and ₩335.3B respectively. Wooree BioLtd's EBIT is ₩28.1B making its interest coverage ratio 15.6. It has cash and short-term investments of ₩146.5B.
Key information
25.1%
Debt to equity ratio
₩64.76b
Debt
Interest coverage ratio | 15.6x |
Cash | ₩146.54b |
Equity | ₩258.25b |
Total liabilities | ₩335.31b |
Total assets | ₩593.56b |
Recent financial health updates
Is Wooree BioLtd (KOSDAQ:082850) A Risky Investment?
Aug 10These 4 Measures Indicate That Wooree BioLtd (KOSDAQ:082850) Is Using Debt Reasonably Well
May 03Here's Why Wooree BioLtd (KOSDAQ:082850) Can Manage Its Debt Responsibly
Feb 01Recent updates
Is Wooree BioLtd (KOSDAQ:082850) A Risky Investment?
Aug 10Wooree Bio Co.,Ltd's (KOSDAQ:082850) Shares Climb 37% But Its Business Is Yet to Catch Up
Jul 19Wooree BioLtd's (KOSDAQ:082850) Earnings Seem To Be Promising
May 25These 4 Measures Indicate That Wooree BioLtd (KOSDAQ:082850) Is Using Debt Reasonably Well
May 03Wooree Bio Co.,Ltd's (KOSDAQ:082850) Share Price Boosted 50% But Its Business Prospects Need A Lift Too
Apr 26Should You Invest In Wooree BioLtd (KOSDAQ:082850)?
Feb 28Here's Why Wooree BioLtd (KOSDAQ:082850) Can Manage Its Debt Responsibly
Feb 01Is Wooree Bio Co.,Ltd's (KOSDAQ:082850) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Jan 12Wooree BioLtd (KOSDAQ:082850) Shareholders Have Enjoyed A Whopping 478% Share Price Gain
Dec 21Here's Why We Think Wooree BioLtd's (KOSDAQ:082850) Statutory Earnings Might Be Conservative
Nov 29Financial Position Analysis
Short Term Liabilities: A082850's short term assets (₩463.3B) exceed its short term liabilities (₩311.3B).
Long Term Liabilities: A082850's short term assets (₩463.3B) exceed its long term liabilities (₩24.0B).
Debt to Equity History and Analysis
Debt Level: A082850 has more cash than its total debt.
Reducing Debt: A082850's debt to equity ratio has reduced from 103.9% to 25.1% over the past 5 years.
Debt Coverage: A082850's debt is well covered by operating cash flow (84.9%).
Interest Coverage: A082850's interest payments on its debt are well covered by EBIT (15.6x coverage).